Latest filing published 02 Oct 2017 for Oncternal Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Pyramid Peak Foundation: trading record in brief
Pyramid Peak Foundation discloses dealings in Oncternal Therapeutics, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 14 November 2014 to 29 September 2017.
No open-market sale appears; the market trades are 3 purchases worth €5.7M. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2017 to date brings 1 purchase and no sales.
The latest filing, published on 2 October 2017, reports an open-market purchase in Oncternal Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Pyramid Peak Foundation
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 565,291 sharesCommon StockSEC:0001140361-17-037138:0Canonical exit: 28 Dec 2017 (T+90)
- 7,716,049 shares@ US$0.81100.0% of flowCommon StockSEC:0001140361-16-082869:0Canonical exit: 12 Jan 2017 (T+90)
- 24,545,455 sharesCommon StockSEC:0001140361-14-042696:0Canonical exit: 12 Feb 2015 (T+90)
3 of 3 declarations
